Pharmacology of the immunomodulator Trekrezan
A. B. Zhumasheva · 2009 · Kirov Military Medical Academy; dissertation author’s abstract
What does this source report?
The dissertation transcription compares Trekrezan, Metaprot and Polyoxidonium, including combinations. Trekrezan plus Metaprot produced larger changes in selected energy-metabolism and immune endpoints than either alone.
- Population and setting
- Experimental immune models, including bronchopulmonary inflammation in rats
- Evidence type
- Animal / experimental
- Preparation
- See the original report; formulation details require verification.
- Source language
- Russian; English abstract where indicated
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- Author’s abstract/transcription is not a completed appraisal of the original thesis.
- This is animal combination research, not a human regimen or independent replication of the same programme.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Document format: Author’s-abstract transcription
Review depth: Selected experimental passages
Source access and review scope
Citation and available abstract or selected source passages checked; complete methods and risk-of-bias appraisal pending.
Recorded source-check date: 2026-10-02. This date does not imply a completed systematic review.
Cite and trace this record
Original source: A. B. Zhumasheva. Pharmacology of the immunomodulator Trekrezan Kirov Military Medical Academy; dissertation author’s abstract 2009.
Molekul research summary: https://molekul.io/research/trek-zhumasheva-2009. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entryRelated compound profiles
Trekrezan
A research lineage linking synthetic adaptogen chemistry with Kirov environmental-stress and immune-metabolism programmes. Human cold-exposure work, animal hypoxia studies and experimental combinations are distinguished below.
Bemitil
A benzimidazole-derived actoprotector, also indexed as bemethyl and Metaprot. Research spans patient asthenia, occupational settings, neuromuscular and liver studies, metabolism and preclinical safety; these are research contexts, not established uses.